BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 28629653)

  • 1. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
    Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
    Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study.
    Cho JK; Lee W; Jang JY; Kim HG; Kim JM; Kwag SJ; Park JH; Kim JY; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Jeong CY
    World J Surg Oncol; 2019 Jan; 17(1):8. PubMed ID: 30616645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
    Aramaki M; Matsumoto T; Shibata K; Himeno Y; Yada K; Hirano S; Sasaki A; Kawano K; Kitano S
    Hepatogastroenterology; 2004; 51(60):1609-11. PubMed ID: 15532788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.
    Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    Hepatogastroenterology; 2012; 59(113):36-41. PubMed ID: 22251521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Surgical Procedures for T2 Gallbladder Cancer in Terms of Recurrence and Prognosis.
    Kawahara R; Shirahama T; Arai S; Muroya D; Nomura Y; Fukutomi S; Shirahama N; Takagi K; Goto Y; Akashi M; Maruyama Y; Sakai H; Ishikawa H; Hisaka T; Yasunaga M; Horiuchi H; Okuda K; Akagi Y; Tanaka H
    Kurume Med J; 2017 Apr; 63(1.2):15-22. PubMed ID: 28331137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic spread of T2 gallbladder carcinoma: Regional lymphadenectomy is required independent of tumor location.
    Toge K; Sakata J; Hirose Y; Yuza K; Ando T; Soma D; Katada T; Miura K; Takizawa K; Kobayashi T; Wakai T
    Eur J Surg Oncol; 2019 Aug; 45(8):1446-1452. PubMed ID: 30962045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic Outcomes of Extended Lymphadenectomy without Liver Resection for T1/T2 Gallbladder Cancer.
    Chong JU; Lee WJ
    Yonsei Med J; 2019 Dec; 60(12):1138-1145. PubMed ID: 31769244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes.
    Shirai Y; Sakata J; Wakai T; Ohashi T; Ajioka Y; Hatakeyama K
    World J Surg Oncol; 2012 May; 10():87. PubMed ID: 22594526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.
    Foster JM; Hoshi H; Gibbs JF; Iyer R; Javle M; Chu Q; Kuvshinoff B
    Ann Surg Oncol; 2007 Feb; 14(2):833-40. PubMed ID: 17103074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location.
    Lee H; Choi DW; Park JY; Youn S; Kwon W; Heo JS; Choi SH; Jang KT
    Ann Surg Oncol; 2015 Aug; 22(8):2779-86. PubMed ID: 25519930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
    Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
    J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The standardized surgical approach improves outcome of gallbladder cancer.
    Scheingraber S; Justinger C; Stremovskaia T; Weinrich M; Igna D; Schilling MK
    World J Surg Oncol; 2007 May; 5():55. PubMed ID: 17517122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
    Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
    Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer.
    Jung W; Jang JY; Kang MJ; Chang YR; Shin YC; Chang J; Kim SW
    Gut Liver; 2016 Jan; 10(1):140-6. PubMed ID: 26347513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing survival rate and appropriate surgery methods according to tumor location in T2 gallbladder cancer.
    Sung MK; Lee W; Lee JH; Song KB; Kim SC; Kwak BJ; Hwang DW
    Surg Oncol; 2022 Mar; 40():101693. PubMed ID: 34923377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.
    He XD; Li JJ; Liu W; Qu Q; Hong T; Xu XQ; Li BL; Wang Y; Zhao HT
    World J Gastroenterol; 2015 Apr; 21(15):4620-6. PubMed ID: 25914471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study.
    Kwon W; Kim H; Han Y; Hwang YJ; Kim SG; Kwon HJ; Vinuela E; Járufe N; Roa JC; Han IW; Heo JS; Choi SH; Choi DW; Ahn KS; Kang KJ; Lee W; Jeong CY; Hong SC; Troncoso AT; Losada HM; Han SS; Park SJ; Kim SW; Yanagimoto H; Endo I; Kubota K; Wakai T; Ajiki T; Adsay NV; Jang JY
    Br J Surg; 2020 Sep; 107(10):1334-1343. PubMed ID: 32452559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
    Yun SP; Shin N; Seo HI
    World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.
    Shindoh J; de Aretxabala X; Aloia TA; Roa JC; Roa I; Zimmitti G; Javle M; Conrad C; Maru DM; Aoki T; Vigano L; Ribero D; Kokudo N; Capussotti L; Vauthey JN
    Ann Surg; 2015 Apr; 261(4):733-9. PubMed ID: 24854451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection.
    Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    J Gastrointest Surg; 2010 Apr; 14(4):668-78. PubMed ID: 20033339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.